MRC1 and neoplasm: The impact of PEG-MnMOF@PTX on the immunosuppressive TME was comprehensively assessed by analyzing M2-TAMs (CD11b+ F4/80+ CD206+) and infiltration of MDSC (CD11b+ Gr-1+) in the tumor cells using FCM.